Myocardial Infarction: Prevention, Treatment and Outcomes
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425).
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 1282
Special Issue Editors
Interests: internal medicine; cardiothoracic surgery (clinical training); myocardial infarction; acute heart failure; acute coronary syndrome; unstable angina pectoris
Special Issue Information
Dear Colleagues,
Myocardial infarction is a leading cause of death worldwide, resulting from the interruption of myocardial blood flow and the consequent ischemia. Myocardial infarction is conditioned by numerous risks, such as smoking, hypertension, low-density lipoprotein (LDL) cholesterol, hyperlipidemia, diabetes, and so on. It is vital to take action in order to lower those risks and prevent myocardial infarction. In recent years, significant transformations have taken place in the treatment and outcomes of myocardial infarction. Currently, 95% of patients hospitalized with an MI survive due to improvements in the treatment techniques. Percutaneous coronary intervention is the main and most effective intervention. Drug-eluting stents or P2Y12 inhibitors have also demonstrated their substantial benefits to patients. However, drug duration and the incidence of reperfusion injury remain substantial challenges in the field.
This Special Issue aims to provide an open forum for those attempting to overcome these challenges, whether by reporting their research or by providing comments for review articles. We look forward to receiving your contributions.
Prof. Dr. Jacek Kubica
Dr. Piotr Adamski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- myocardial infarction
- coronary artery disease
- percutaneous coronary intervention
- acute coronary syndrome
- drug treatment